Ozempic

NAFDAC Raises Alarm Over Falsely Labeled Anti-Diabetic Drug in Circulation

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public warning concerning a falsely labeled anti-diabetic drug, Ozempic,...